Chunshuen Au
Physician Assistant · Flushing, NYNPI 1790043859
Payments from drug & device makers
Across 442 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Gilead$2K
- Boehringer Ingelheim$1K
- Novo Nordisk$1K
- GSK$750
- Amgen$634
- plus $2K from 15 others
What the payments were for
- Food & beverage$11,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 101 | $3,034 |
| Gilead | 65 | $2,207 |
| Boehringer Ingelheim | 61 | $1,475 |
| Novo Nordisk | 60 | $1,196 |
| GSK | 40 | $750 |
| Amgen | 28 | $634 |
| Lilly USA, LLC | 21 | $464 |
| Amarin Pharma, Inc. | 14 | $298 |
| Esperion Therapeutics, Inc. | 14 | $289 |
| AbbVie | 10 | $220 |
| Astellas Pharma US Inc | 10 | $171 |
| Corium, LLC | 3 | $66 |
| Viiv Healthcare Company | 2 | $61 |
| Pfizer | 2 | $51 |
| IBSA Pharma Inc. | 2 | $50 |
| Merck | 2 | $42 |
| Seqirus USA Inc | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,144 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 609 | $535,914 |
| VascepaIcosapent Ethyl | 1,088 | $459,905 |
| RestasisCyclosporine | 269 | $191,949 |
| JardianceEmpagliflozin | 161 | $135,140 |
| VemlidyTenofovir Alafenamide | 73 | $102,674 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 145 | $98,934 |
| FarxigaDapagliflozin Propanediol | 116 | $97,690 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 38 | $71,026 |
| EliquisApixaban | 104 | $68,357 |
| NexiumEsomeprazole Magnesium | 219 | $67,162 |
| CreonLipase/Protease/Amylase | 41 | $62,585 |
| TradjentaLinagliptin | 78 | $61,360 |
| JanumetSitagliptin Phos/Metformin Hcl | 71 | $50,550 |
| RybelsusSemaglutide | 46 | $49,663 |
| Diclofenac Sodium | 210 | $48,415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Creon, Linzess | $220 | $293,291360 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Nexium | $3,034 | $263,785480 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Spiriva Respimat | $1,475 | $219,219282 claims |
| GileadVemlidy | $2,207 | $102,67473 claims |
| Novo NordiskRybelsus, Ozempic | $1,196 | $96,14781 claims |
| MerckJanumet, Januvia | $42 | $90,702126 claims |
| PfizerEliquis | $51 | $68,357104 claims |
| Astellas Pharma US IncMyrbetriq | $171 | $39,10271 claims |
| GSKAnoro Ellipta, Trelegy Ellipta | $750 | $35,50265 claims |
| Johnson & JohnsonXarelto | $17 | $30,95739 claims |
| AmgenProlia | $634 | $22,32313 claims |
| Lilly USA, LLCTrulicity | $464 | $10,81411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Flushing
- Si BongFlushing$27K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.